Miriam Hegemann
Klinikum Sindelfingen-Böblingen · 16 works · 430 citations · h-index 8
Top works
- Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): a randomised, double-blind, phase 3 trial
- Rare and changeable as a chameleon: paraneoplastic syndromes in renal cell carcinoma
- Liquid biopsy: ready to guide therapy in advanced prostate cancer?
- The geometrical shape of mesenchymal stromal cells measured by quantitative shape descriptors is determined by the stiffness of the biomaterial and by cyclic tensile forces
- Denosumab treatment in the management of patients with advanced prostate cancer: clinical evidence and experience
- Stretching human mesenchymal stromal cells on stiffness-customized collagen type I generates a smooth muscle marker profile without growth factor addition
- Circulating tumor cells and their role in prostate cancer
- Welchen Einfluss hat die Dauer der Oberarzttätigkeit auf die Berufsausübung und Zufriedenheit urologischer OberärztInnen in Deutschland?
- Current concepts and trends in the treatment of bone metastases in patients with advanced prostate cancer
- TKI 2.0 – Wandel in der medikamentösen Therapie des Nierenzellkarzinoms
- 70/m mit Makrohämaturie und kolikartigen Flankenschmerzen: Vorbereitung auf die Facharztprüfung: Fall 2
- 70/m mit Makrohämaturie und kolikartigen Flankenschmerzen
- 62/m akute Lumbago und prostataspezifisches Antigen 1430 ng/ml
- First-Line Treatment with Tivozanib for Metastatic Renal Cell Carcinoma in Real-World Settings Across Germany: Results of the Prospective, Non-Interventional, Post-Approval Study T-Rex
- T-Rex study: Quality of life assessment using novel CTCAE-PRO and FKSI-19 in first-line treatment of metastatic renal cell carcinoma with tivozanib.
- [70/m with macrohematuria and intermittent flank pain : Preparation for the medical specialist examination: part 2].